Cognito’s wearable device boosts brain proteins linked to Alzheimer’s protection (opens in new tab)

Cognito Therapeutics will present new data at the Alzheimer’s Association International Conference (AAIC) 2026 in London showing the effects of its investigational device Spectris on lipid transport biomarkers in Alzheimer’s disease. The poster Spectris Sensory Stimulation Increases CSF HDL-like Lipid Transport Proteins In Alzheimer’s Disease is scheduled for 13 July 2026 in Exhibit Hall at […] The post appeared first on <a href="